| Literature DB >> 18817870 |
A Jacquet1, H Francois, C Frangie, L Ahmad, B Charpentier, A Durrbach.
Abstract
Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18817870 DOI: 10.1016/j.trim.2008.09.002
Source DB: PubMed Journal: Transpl Immunol ISSN: 0966-3274 Impact factor: 1.708